The clinical histories disclosed that systemic lupus erythematosus may have its onset as a pulmonary problem, but involvement of the respiratory system generally occurred during the illness.

Infliximab and efzofitimod may be effective in pulmonary sarcoidosis and tofacitinib and adalimumab in cutaneous sarcoidosis.

Infants with cyanotic congenital heart disease palliated with placement of a systemic-to-pulmonary-artery shunt are at risk for shunt thrombosis and death. We investigated whether the addition of c ...

Patients diagnosed with systemic sclerosis-related pulmonary hypertension in the last 10 years had better survival than those diagnosed prior, according to results published in American Journal of ...

Genentech’s Actemra becomes the first biologic therapy approved by the FDA for slowing the rate of decline in pulmonary function in adults with systemic sclerosis-associated interstitial lung ...

Abstract and Introduction Abstract Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide and is characterized by chronic inflammation in both the ...

Immunosuppression appears to reduce mortality among people with systemic sclerosis with pulmonary arterial hypertension but did not prevent the complication from occurring.

Panelists discuss how healthcare resource utilization is primarily driven by hospitalizations, medication costs, and ...

Researchers studied the changes of pulmonary artery systolic pressure among patients with interstitial lung disease associated with systemic sclerosis receiving rituximab therapy.

Those with pulmonary hypertension may experience shortness of breath, lightheadedness and chest pain, according to the National Heart, Lung and Blood Institute. Rose-Jones said she treats several ...